Rosebud Bio
Industrializing organoids for drug discovery
San Francisco, United States · Founded 2020 · $870K raised
- Headquarters
- San Francisco, California
- Employees
- 1–10
- Founded
- 2020
- Business Model
- B2B
- Total Funding
- $870K
- Last Round
- $270K GrantAug 2023
- Rounds
- 2
About
Rosebud Biosciences is an early-stage biotech startup that models human genetic diseases using iPSC-derived organoids to discover and screen drugs for rare pediatric conditions. Their automated platform predicts drug efficacy and screens for off-target toxicities entirely in human tissue models, accelerating translational drug development. Founded in 2020 and backed by Y Combinator, the company targets the 95% of genetic diseases that still lack approved treatments.
Summary
Rosebud Bio is a Drug Discovery company based in San Francisco, United States, founded in 2020. It has raised $870K in total across 2 rounds, most recently a $270K Grant round in Aug 2023.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Aug 2023
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Similar Companies
OpenAI is an AI research and deployment company dedicated to ensuring that general-purpose artifi...
Databricks is the pioneer of the data lakehouse, a unified platform for data science, machine lea...
AI-powered platform designed for immigration law firms
Food and facilities management services
Visma is a European provider of mission-critical enterprise resource planning software and servic...
For more than 30 years, BMC has helped thousands of companies around the world master IT complexi...